Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
With the development of new RA therapeutics, overall treatment outcomes advanced in the past decade.
Preguntar a la IA
Me gusta
Guardar
Compartir
Ver artículo completo
Preguntar a la IA
Me gusta
Guardar
Compartir
Ver artículo completo
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort | Synapse